Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial

    91236.pdf (262.2Kb)
    Access Status
    Open access
    Authors
    McKetin, Rebecca
    Quinn, B.
    Higgs, Peter
    Berk, M.
    Dean, O.M.
    Turner, A.
    Kelly, P.J.
    Lubman, D.I.
    Carter, G.
    Baker, A.L.
    Manning, V.
    Thomas, T.
    Bathish, R.
    Raftery, D.
    Saunders, L.
    Wrobel, A.
    Meehan, A.
    Sinclair, B.
    Reid, D.
    Arunogiri, S.
    Hill, H.
    Cordaro, F.
    Dietze, Paul
    Date
    2021
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    McKetin, R. and Quinn, B. and Higgs, P. and Berk, M. and Dean, O.M. and Turner, A. and Kelly, P.J. et al. 2021. Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial. Drug and Alcohol Review. 40 (7): pp. 1249-1255.
    Source Title
    Drug and Alcohol Review
    DOI
    10.1111/dar.13183
    ISSN
    0959-5236
    Faculty
    Faculty of Health Sciences
    School
    EnAble Institute
    Funding and Sponsorship
    http://purl.org/au-research/grants/nhmrc/1128147
    http://purl.org/au-research/grants/nhmrc/1135901
    http://purl.org/au-research/grants/nhmrc/1136908
    http://purl.org/au-research/grants/nhmrc/1156072
    http://purl.org/au-research/grants/nhmrc/1145634
    http://purl.org/au-research/grants/nhmrc/1059660
    URI
    http://hdl.handle.net/20.500.11937/91412
    Collection
    • Curtin Research Publications
    Abstract

    Introduction and Aims: There has been a rapid increase in smoking crystalline methamphetamine in Australia. We compare the clinical and demographic characteristics of those who smoke versus inject the drug in a cohort of people who use methamphetamine. Design and Methods: Participants (N = 151) were dependent on methamphetamine, aged 18–60 years, enrolled in a pharmacotherapy trial for methamphetamine dependence, and reported either injecting (n = 54) or smoking (n = 97) methamphetamine. Measures included the Timeline Followback, Severity of Dependence Scale, Amphetamine Withdrawal Questionnaire, Craving Experience Questionnaire and the Brief Psychiatric Rating Scale (symptoms of depression, hostility, psychosis and suicidality). Simultaneous regression was used to identify independent demographic correlates of smoking methamphetamine and to compare the clinical characteristics of participants who smoked versus injected. Results: Compared to participants who injected methamphetamine, those who smoked methamphetamine were younger and less likely to be unemployed, have a prison history or live alone. Participants who smoked methamphetamine used methamphetamine on more days in the past 4 weeks than participants who injected methamphetamine (26 vs. 19 days, P = 0.001); they did not differ significantly in their severity of methamphetamine dependence, withdrawal, craving or psychiatric symptoms (P > 0.05). After adjustment for demographic differences, participants who smoked had lower craving [b (SE) = −1.1 (0.5), P = 0.021] and were less likely to report psychotic symptoms [b (SE) = −1.8 (0.7), P = 0.013] or antidepressant use [b (SE) = −1.1 (0.5), P = 0.022]. Discussion and Conclusions: Smoking crystalline methamphetamine is associated with a younger less marginalised demographic profile than injecting methamphetamine, but a similarly severe clinical profile.

    Related items

    Showing items related by title, author, creator and subject.

    • A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence
      McKetin, Rebecca ; Dean, O.M.; Turner, A.; Kelly, P.J.; Quinn, B.; Lubman, D.I.; Dietze, Paul ; Carter, G.; Higgs, Peter ; Baker, A.L.; Sinclair, B.; Reid, D.; Manning, V.; Te Pas, N.; Liang, Wenbin ; Thomas, T.; Bathish, R.; Kent, M.; Raftery, D.; Arunogiri, S.; Cordaro, F.; Hill, H.; Berk, M. (2019)
      Background: There are currently no approved pharmacotherapies for managing methamphetamine dependence. N-acetylcysteine (NAC) has been found to reduce the craving for methamphetamine and other drugs, but its effect on ...
    • A systematic review of risk factors for methamphetamine-associated psychosis
      Arunogiri, S.; Foulds, J.; McKetin, Rebecca; Lubman, D. (2018)
      Objective: Chronic methamphetamine use is commonly associated with the development of psychotic symptoms. The predictors and correlates of methamphetamine-associated psychosis are poorly understood. We sought to systematically ...
    • Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study
      McKetin, Rebecca; Kothe, A.; Baker, A.; Lee, N.; Ross, J.; Lubman, D. (2017)
      Introduction and Aims. We previously found that residential rehabilitation increased continuous abstinence from methamphetamine use 1 year after treatment. We examine what client and treatment characteristics predict this ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.